Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,291.50
Bid: 1,291.00
Ask: 1,292.00
Change: 23.00 (1.81%)
Spread: 1.00 (0.077%)
Open: 1,279.50
High: 1,294.00
Low: 1,270.00
Prev. Close: 1,268.50
PSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Covid-19, Capital Return Plan and AGM Updates

25 Mar 2020 07:00

RNS Number : 4710H
Persimmon PLC
25 March 2020
 

Covid-19, Capital Return Plan and AGM Updates

 

Persimmon plc ("Persimmon" or the "Company") today announces how it is responding to the Covid-19 virus and is providing an update to its Capital Return Plan payments in 2020 and forthcoming Annual General Meeting ("AGM").

 

Responding to the Covid-19 Virus

 

Since the outbreak of the virus in the UK, Persimmon has closely followed Public Health England's guidance including instituting social distancing practices to ensure the safety of its customers, staff, contractors and suppliers throughout this period. Following enhanced Government and Public Health England guidance on Monday 23 March, we are now taking further measures including closing all of Persimmon's sales offices from Thursday 26 March until further notice. While we will continue to support existing and new customers on the telephone and / or online, all customer care site visits will cease except for emergencies. All Persimmon regional offices will also close, with only a skeleton staff to facilitate the wider workforce working from home. Construction sites are commencing an orderly shutdown with only essential work taking place which will be focused on making partly built homes safe and secure and where failure to complete the build could put customers in a vulnerable position.

 

Balance Sheet Conservatism and Capital Return Plan Update

 

Persimmon entered this period of uncertainty with a robust operational performance in the year to date and a strong forward order book. Despite this encouraging start to the financial year we are preparing for a significant delay in the timing of legal completions, a rise in cancellation rates and a material slowdown in new sales, the extent and duration of which is uncertain.

 

In light of the current uncertainty caused by the Covid-19 virus and its operational impact on UK economic activity, and in line with the Group's strategy of minimising the financial risk through the cycle, the Board believes that conserving cash and maximising financial flexibility is in the long term best interests of the business and all its stakeholders.

 

Accordingly, the Board of Persimmon has decided to: (i) cancel the proposed 125p per share interim dividend payment of surplus capital to shareholders on 2 April 2020; and (ii) to postpone the proposed annual, final dividend payment of 110p per share on 6 July 2020 and reassess it later in the calendar year when the effects of the virus will be clearer. Whilst the Company's regular annual payment of at least 110p per share has been stress tested for payment through the housebuilding industry cycle, the Covid-19 virus presents an exceptional set of circumstances.

 

Persimmon entered the current year with a strong balance sheet including cash holdings of £844m, land creditors of £435m (£268m payable over 2020) and industry leading land holdings of 93,246 plots owned and under control. The Board remains confident of the Group's future prospects. The Group's current cash position of c. £610m (as at 20 March 2020), deferred land commitments of c. £195m to the end of the current year, availability of the Group's £300m Revolving Credit Facility, together with the measures the Board is taking to manage the cash flows of the business, will preserve the strength of the Group during this unprecedented period of uncertainty.

 

The decisions taken by the Board today in no way diminishes its confidence in the long-term outlook for the Company and the strength of the through-the-cycle model, which is set up to withstand reasonable downside scenarios and to take advantage of opportunities as they arise. The Board remains committed to evaluating an ordinary course payment of 110p per share to shareholders this year, should economic and business disruption abate in the next several months. Whilst the Board is disappointed in cancelling the 125p per share payment of surplus capital, the Board does not believe it would be prudent at this time to regard this cash as surplus, and the cancellation reflects a change in the Board's assessment of the Company's financial prospects this year and the broader economic risk profile, in line with the stated policy.

 

At this stage, given the level of continued uncertainty around economic and business activity, it is not possible to provide financial guidance for the FY20 financial year. 

 

Annual General Meeting Update

 

The Company's AGM is due to be held on Wednesday 29 April 2020. In light of the Government's and Public Health England's advice, the Board has taken the decision to move the location of the AGM to the Company's Head Office at Persimmon House, Fulford, York, YO19 4FE.

 

The well-being of our shareholders is vitally important to us and we recommend that shareholders adhere to the current instructions to stay at home. To enable shareholders to listen to the proceedings of the meeting from their homes, the proceedings will be available by a webcast. There will be an opportunity for shareholders to ask the Board of Directors questions on the formal business of the meeting and further details will be on our website in due course.

 

The Company will ensure that the meeting adheres to the Government's and Public Health England's advice around social distancing and enhanced hygiene measures will be in place. To further support these efforts there will be only limited Company representation at the meeting. We will also reduce the length of the meeting by limiting it to the formal business required.

 

We encourage shareholders to submit their proxies as early as possible. Further information on how shareholders can submit their proxies can be found in the Notice of 2020 Annual General Meeting (the "Notice") and is available on our website. Please note the deadline for submitting proxies will be 12.00pm on Monday 27 April 2020.

 

In view of the Company's decision to postpone the proposed 110p per share payment, the Board announces its intention to withdraw Resolution 2 as set out in the Notice, dated 17 March 2020, relating to the proposed payment of a final dividend for 2019.

 

A trading update will be provided by the Company in advance of its AGM.

 

Dave Jenkinson, Group Chief Executive, said:

 

"Our primary concern is the safety and well-being of our customers, staff, contractors and suppliers and we have today set out a number of further measures throughout the business to protect them for the duration of the pandemic. We will listen carefully to the Government's future advice as the situation develops and will make further adjustments where necessary.

 

"The Group's long-term strategy of minimising financial risk and maintaining capital discipline over the long term through the housing cycle, ensures that we are well placed as we enter this period of uncertainty. Whilst the impacts of this pandemic go beyond the normal cyclical nature of the housing market, the Group's high quality land holdings, significant liquidity and strong balance sheet will allow us to work through these challenges and emerge in a strong position for the benefit of all our stakeholders."

 

This announcement contains inside information. The person responsible for arranging the release of this announcement on behalf of the Group is Tracy Davison, Company Secretary.

 

For further information please contact:

 

Dave Jenkinson, Group Chief Executive

Simon Rigby

Mike Killoran, Group Finance Director

Kevin Smith

Persimmon Plc

Jos Bieneman

Tel: +44 (0) 20 7638 9571 (on 25 March 2020)

Ellen Wilton

Tel: +44 (0) 1904 642199 (thereafter)

 

Citigate Dewe Rogerson

Tel: +44 (0) 20 7638 9571

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCPPUPUWUPUPPC
Date   Source Headline
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company
8th Nov 20237:00 amRNSAppointment of Chief Financial Officer
7th Nov 20237:00 amRNSQ3 Trading Statement
3rd Nov 20231:15 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
10th Aug 20237:04 amRNSHalf Year Results
27th Jul 202310:13 amRNSDirectorate Change
10th Jul 20239:27 amRNSDirector Declaration
3rd Jul 20232:46 pmRNSTotal Voting Rights
1st Jun 20234:38 pmRNSTR-1: Notification of major holdings
1st Jun 20231:07 pmRNSBlock listing Interim Review
1st Jun 202311:06 amRNSTotal Voting Rights
3rd May 20235:00 pmRNSHolding(s) in Company
3rd May 20234:12 pmRNSDirector/PDMR Shareholding
2nd May 202311:13 amRNSTotal Voting Rights
26th Apr 20234:32 pmRNSResult of AGM
26th Apr 20237:00 amRNSQ1 Trading Statement
3rd Apr 20234:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:05 pmRNSTotal Voting Rights
27th Mar 20233:44 pmRNSDirector/PDMR Shareholding
22nd Mar 20233:00 pmRNSAnnual Report 2022 and Notice of AGM 2023
13th Mar 20231:57 pmRNSDirectorate Change
13th Mar 202312:19 pmRNSUK Government Self Remediation Contract Signed
7th Mar 20235:33 pmRNSHolding(s) in Company
7th Mar 20237:04 amRNSDirector Declaration
6th Mar 20235:02 pmRNSHolding(s) in Company
1st Mar 20237:00 amRNSFull Year Results
12th Jan 20237:00 amRNSTrading Statement
1st Dec 20225:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20225:25 pmRNSVoting Rights and Capital
8th Nov 20227:00 amRNSTrading Statement
1st Nov 20221:00 pmRNSTotal Voting Rights
1st Nov 20229:24 amRNSHolding(s) in Company
10th Oct 20222:24 pmRNSDirector/PDMR Shareholding
5th Oct 202210:26 amRNSHolding(s) in Company
4th Oct 20223:07 pmRNSDirector/PDMR Shareholding
3rd Oct 20222:12 pmRNSTotal Voting Rights
22nd Sep 20223:54 pmRNSDirector/PDMR Shareholding
17th Aug 20227:00 amRNSHalf Year Results
1st Aug 20222:30 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.